TP53 and Li-Fraumeni syndrome: Similarly, the R167H mutation was chosen as its human equivalent (R175H) is commonly found in human cancers [11] as well as the cancer predisposition Li-Fraumeni Syndrome [14], and when introduced into the endogenous murine [12] or porcine [13] TP53 gene, induces tumors.